MicroRNA-25 regulates small cell lung cancer cell development and cell cycle through cyclin E2.

作者: Changlei Wang , Juntao Liu , Zhengyuan Zhao , Youguo Jiang , Yi Wang

DOI:

关键词: Cyclin BCell growthCell cycleCyclin A2Cyclin ABiologyCell cycle checkpointCyclin DCell biologyCyclin E2

摘要: Purpose: We intended to examine the underlying mechanism of microRNA-25 (miR-25) in regulating small cell lung cancer (SCLC). Methods: The miR-25 expression was measured by quantitative RT-PCR (qRT-PCR) 5 SCLC lines and 9 human tissues. In line H510A cells, endogenous downregulated stable transfection antisense oligonucleotide (miR-25-as). Then effects downregulation on growth, invasion chemoresistance were assessed MTT, migration cisplatin assays, respectively. Furthermore, cycle arrest, production proteins cyclin E2 CDK2 examined assay, western blot luciferase Finally, over-expressed cells investigate its effect mediated regulation. Results: both tumor tissues, overexpressed. Down-regulation significantly reduced invasive capability resistance cisplatin. Also, it induced G1 arrest related CDK2. Luciferase assay demonstrated directly targeted miR-25. Overexpression reversed restored impaired downregulation. Conclusions: Our study shows is overexpressed acting as oncogenic regulator E2.

参考文章(29)
Bryan A. Chan, Jermaine I. G. Coward, Chemotherapy advances in small-cell lung cancer. Journal of Thoracic Disease. ,vol. 5, ,(2013) , 10.3978/J.ISSN.2072-1439.2013.07.43
H-W Hwang, J T Mendell, MicroRNAs in cell proliferation, cell death, and tumorigenesis. British Journal of Cancer. ,vol. 94, pp. 776- 780 ,(2006) , 10.1038/SJ.BJC.6603023
Yang Li, Weiqi Tan, Thomas W.L. Neo, Myat O. Aung, Shanthi Wasser, Seng G. Lim, Theresa M.C. Tan, Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma Cancer Science. ,vol. 100, pp. 1234- 1242 ,(2009) , 10.1111/J.1349-7006.2009.01164.X
J Ma, C Dong, C Ji, MicroRNA and drug resistance. Cancer Gene Therapy. ,vol. 17, pp. 523- 531 ,(2010) , 10.1038/CGT.2010.18
David Santamaria, Cyclins and CDKS in development and cancer: lessons from genetically modified mice Frontiers in Bioscience. ,vol. 11, pp. 1164- 1188 ,(2006) , 10.2741/1871
Chang Hee Kim, Hark K Kim, R Luke Rettig, Joseph Kim, Eunbyul T Lee, Olga Aprelikova, Il J Choi, David J Munroe, Jeffrey E Green, miRNA signature associated with outcome of gastric cancer patients following chemotherapy BMC Medical Genomics. ,vol. 4, pp. 79- 79 ,(2011) , 10.1186/1755-8794-4-79
Susan S. Devesa, Freddie Bray, A. Paloma Vizcaino, D. Max Parkin, International lung cancer trends by histologic type: Male:Female differences diminishing and adenocarcinoma rates rising International Journal of Cancer. ,vol. 117, pp. 294- 299 ,(2005) , 10.1002/IJC.21183
Zhiling Zhu, MiR-25 Regulates Apoptosis by Targeting Bim in Human Ovarian Cancer Oncology Reports. ,vol. 27, pp. 594- 598 ,(2011) , 10.3892/OR.2011.1530
Weiqi Tan, Yang Li, Seng-Gee Lim, Theresa MC Tan, miR-106b-25/miR-17-92 clusters: Polycistrons with oncogenic roles in hepatocellular carcinoma World Journal of Gastroenterology. ,vol. 20, pp. 5962- 5972 ,(2014) , 10.3748/WJG.V20.I20.5962
Lin He, J. Michael Thomson, Michael T. Hemann, Eva Hernando-Monge, David Mu, Summer Goodson, Scott Powers, Carlos Cordon-Cardo, Scott W. Lowe, Gregory J. Hannon, Scott M. Hammond, A microRNA polycistron as a potential human oncogene Nature. ,vol. 435, pp. 828- 833 ,(2005) , 10.1038/NATURE03552